WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2022 Issue has been successfully launched on 1 August 2022.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 August Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREDICTION OF PREECLAMPSIA USING PLACENTAL GROWTH FACTOR AS AN ADJUNCT MARKER AT (11-13) WEEK GESTATION IN A SAMPLE OF PREGNANT WOMEN IN IRAQ

*Dr. Zubaida Adnan Abdullah and Dr. Anne Khazal Yaseen

ABSTRACT

Introduction: Preeclampsia complicate ?10% of pregnancies and it a major cause of maternal and perinatal morbidity and mortality. The aim of the study to evaluate the use of placental angiogenic marker (PlGF) as early predictor of preeclampsia and its related adverse outcome. Methods: Fifty-four lady between 11th and 13th week of their gestation attending their antenatal complicated pregnancies involving Rh isoimmunization, thyroid dysfunction, connective tissue disorders, liver or kidney diseases and chronic hypertension were excluded. All women were informed about the nature of the study, and all who agreed to participate provided verbal informed consent. The study was approved by the Ethics Committee of the institution. Results: Of the enrolled and followed 54 subjects, 5 (9%) women contracted PE, including 3 delivered before 37 weeks (preterm labor). Apart from body mass index (BMI) and mean arterial pressure (MAP), other risk factors such as advance maternal age, parity, diabetes mellitus and conception method were not found to have a significant association with the occurrence of PE. Receiver operating characteristic curve (ROC) analysis showed PlGF cutoff point of 79.85pg/dl (area under the curve (AUC) = 0.798; P ? 0.029) had the maximum sensitivity and specificity of (80%) for PE prediction. 80% of patients who develop PE have low PlGF. Conclusion: Maternal serum PlGF between 11th and 13th week gestation can be used together with other maternal characteristic (MAP and BMI) as early predictor of PE and PE adverse outcome to identify fetuses requiring increased surveillance and possibly urgent delivery.

[Full Text Article]